Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein

Biochemical and Biophysical Research Communications

Volumn 329, Issue 1, 2005, Pages 356-361

  Nakanishi, Koji ^a,b   Komatsu, Yasuhiko ^c,d   Kogawa, Noriaki ^c,e   Matsushita, Hiroshi ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c JAPAN ENERGY CORPORATION   (Japan)

^d FUJIREBIO INC   (Japan)

^e DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

HLA DR4; Islet; MHC class II; Peptide; Type 1 diabetes

Indexed keywords

AMINO ACID; HEPARAN SULFATE; HEPARAN SULFATE INTERACTING PROTEIN; HEPARIN; HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN; INSULIN; PEPTIDE DERIVATIVE; PROTEIN; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CASE REPORT; EMBRYO CELL; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

HUMAN HERPESVIRUS 4;

EID: 13844276121     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.01.144     Document Type: Article

References (28)

1. R. Tisch, and H. McDevitt Insulin-dependent diabetes mellitus Cell 85 1996 291 297
2. K.S. Rønningen, A. Spurkland, B.D. Tait, B. Drummond, C. Lopez-Larrea, F.S. Baranda, M.J. Menendez-Diaz, S. Caillat-Zucman, G. Beaurain, H.-J. Garchon, J. Ilonen, H. Reijonen, M. Knip, B.O. Boehm, C. Rosak, C. Löliger, P. Kühnl, T. Ottenhoff, L. Contu, C. Carcassi, M. Savi, P. Zanelli, T.M. Neri, K. Hamaguchi, A. Kimura, R.P. Dong, N. Chikuba, S. Nagataki, C. Gorodezky, H. Debaz, C. Robles, H.B. Coimbra, A. Martinho, M.A. Ruas, J.A. Sachs, M. Garcia-Pachedo, A. Biro, A. Nikaein, L. Dombrausky, T. Gonwa, C. Zmijewski, D. Monos, M. Kamoun, Z. Layrisse, M.C. Magli, P. Balducci, and E. Thorsby HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese K. Tsuji M. Aizawa T. Sasazuki HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference 1992 Oxford university press Oxford 713 722
3. C.A. Janeway, P. Travers, M. Walport, and M. Shlomchik Immunobiology. The Immune System in Health and Disease fifth ed. 2001 Garland Publishing New York
4. A. Geluk, K.E. van Meijgaarden, N.C. Schloot, J.W. Drijfhout, T.H.M. Ottenhoff, and B.O. Roep HLA-DR binding analysis of peptides from islet antigens in IDDM Diabetes 47 1998 1594 1601
5. E. Harfouch-Hammoud, T. Walk, H. Otto, G. Jung, J.-F. Bach, P.M. van Endert, and S. Caillat-Zucman Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes Diabetes 48 1999 1937 1947
6. T.P. Astill, R.J. Ellis, S. Arif, T.I.M. Tree, and T.M. Peakman Promiscuous binding of proinsulin peptides to type 1 diabetes-permissive and -protective HLA class II molecules Diabetologia 46 2003 496 503
7. J. Endl, H. Otto, G. Jung, B. Dreisbusch, F. Donie, P. Stahl, R. Elbracht, G. Schmitz, E. Meinl, M. Hummel, A.-G. Ziegler, R. Wank, and D.J. Schendel Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients J. Clin. Invest. 99 1997 2405 2415
8. A.E. Herman, R.M. Tisch, S.D. Patel, S.L. Parry, J. Olson, J.A. Noble, A.P. Cope, B. Cox, M. Congia, and H.O. McDevitt Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif J. Immunol. 163 1999 6275 6282
9. null NOD mice Diabetes 48 1999 469 477
10. C.-C. Chao, H.-K. Sytwu, E.L. Chen, J. Toma, and H.O. McDevitt The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire Proc. Natl. Acad. Sci. USA 96 1999 9299 9304
11. L.S. Wicker, S.-L. Chen, G.T. Nepom, J.F. Elliott, D.C. Freed, A. Bansal, S. Zheng, A. Herman, Å. Lernmark, D.M. Zaller, L.B. Peterson, J.B. Rothbard, R. Cummings, and P.J. Whiteley Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401 J. Clin. Invest. 98 1996 2597 2603
12. M. Peakman, E.J. Stevens, T. Lohmann, P. Narendran, J. Dromey, A. Alexander, A.J. Tomlinson, M. Trucco, J.C. Gorga, and R.M. Chicz Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4 J. Clin. Invest. 104 1999 1449 1457
13. K. Nakanishi, T. Kobayashi, T. Murase, T. Nakatsuji, H. Inoko, K. Tsuji, and K. Kosaka Association of HLA-A24 with complete β-cell destruction in IDDM Diabetes 42 1993 1086 1093
14. M. Ota, T. Seki, H. Fukushima, K. Tsuji, and H. Inoko HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers Tissue Antigens 39 1992 187 202
15. E-P. Reich, H. von Grafenstein, A. Barlow, K.E. Swenson, K. Williams, and C.A. Janeway Jr. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice J. Immunol. 152 1994 2279 2288
16. S.F. Altschul, W. Gish, W. Miller, E.W. Myers, and D.J. Lipman Basic local alignment search tool J. Mol. Biol. 215 1990 403 410
17. P.T.W. Law, S.K.W. Tsui, W.Y. Lam, S.C.W. Luk, D.M. Hwang, C.C. Liew, C.Y. Lee, K.P. Fung, and M.M.Y. Waye A novel cDNA encoding a human homologue of ribosomal protein L29 Biochim. Biophys. Acta 1305 1996 105 108
18. S. Liu, S.E. Smith, J. Julian, L.H. Rohde, N.J. Karin, and D.D. Carson cDNA cloning and expression of HIP, a novel cell surface heparan sulfate/heparin-binding protein of human uterine epithelial cells and cell lines J. Biol. Chem. 271 1996 11817 11823
19. H-G. Rammensee, T. Friede, and S. Stevanović MHC ligands and peptide motifs: first listing Immunogenetics 41 1995 178 228
20. M.P. Davenport, A. Godkin, T. Friede, S. Stevanović, A.C. Willis, A.V.S. Hill, and H.-G. Rammensee A distinctive peptide-binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis Immunogenetics 45 1997 229 232
21. R.M. Chicz, R.G. Urban, J.C. Gorga, D.A.A. Vignali, W.S. Lane, and J.L. Strominger Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles J. Exp. Med. 178 1993 27 47
22. R.M. Chicz, and R.G. Urban Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development Immunol. Today 15 1994 155 160
23. d-peptide complexes reveal that high affinity can be achieved without large anchor residues Immunity 8 1998 319 329
24. d class I molecule Eur. J. Immunol. 23 1993 2005 2010
25. G. Andersson, L. Andersson, D. Larhammar, L. Rask, and S. Sigurdardóttir Simplifying genetic locus assignment of HLA-DRB genes Immunol. Today 15 1994 58 62
26. T. Friede, V. Gnau, G. Jung, W. Keilholz, S. Stevanović, and H.-G. Rammensee Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides Biochim. Biophys. Acta 1316 1996 85 101
27. S. Liu, F. Zhou, M. Höök, and D.D. Carson A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities Proc. Natl. Acad. Sci. USA 94 1997 1739 1744
28. D. Marchetti, S. Liu, W.C. Spohn, and D.D. Carson Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate J. Biol. Chem. 272 1997 15891 15897